BR1100704KB1 - vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli. - Google Patents

vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.

Info

Publication number
BR1100704KB1
BR1100704KB1 BRPP1100704-4KB1A BR1100704A BR1100704KB1 BR 1100704K B1 BR1100704K B1 BR 1100704KB1 BR 1100704 A BR1100704 A BR 1100704A BR 1100704K B1 BR1100704K B1 BR 1100704KB1
Authority
BR
Brazil
Prior art keywords
polypeptide
producing
dna
strain
methods
Prior art date
Application number
BRPP1100704-4KB1A
Other languages
English (en)
Inventor
Katsutoshi Sasaki
Kazumi Miura
Nobuo Hanai
Tatsunari Nishi
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13390376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR1100704K(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of BR1100704KB1 publication Critical patent/BR1100704KB1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BRPP1100704-4KB1A 1993-03-29 1997-05-08 vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli. BR1100704KB1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6901693 1993-03-29

Publications (1)

Publication Number Publication Date
BR1100704KB1 true BR1100704KB1 (pt) 2011-10-18

Family

ID=13390376

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPP1100704-4KB1A BR1100704KB1 (pt) 1993-03-29 1997-05-08 vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli.

Country Status (7)

Country Link
US (2) US7094530B1 (pt)
EP (1) EP0643132B1 (pt)
JP (1) JP3756946B2 (pt)
BR (1) BR1100704KB1 (pt)
DE (1) DE69434749T2 (pt)
SG (1) SG49117A1 (pt)
WO (1) WO1994023021A1 (pt)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595900A (en) * 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1994023021A1 (fr) 1993-03-29 1994-10-13 Kyowa Hakko Kogyo Co., Ltd. α-1,3-FUCOSYLTRANSFERASE
US5858752A (en) * 1995-06-07 1999-01-12 The General Hospital Corporation Fucosyltransferase genes and uses thereof
US5770420A (en) * 1995-09-08 1998-06-23 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
JP2000507095A (ja) * 1996-03-08 2000-06-13 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、ミシガン ネズミα（１，３）フコシルトランスフェラーゼＦｕｃ―ＴＶＩＩ、それをコードするＤＮＡ、その製造法、それを認識する抗体、それを検出するためのイムノアッセイ、このようなＤＮＡを含むプラスミド、およびこのようなプラスミドを含む細胞
AU2957199A (en) * 1998-03-24 1999-10-18 Kyowa Hakko Kogyo Co. Ltd. Antibody against human alpha1,3-fucose transferase fuc-tvii
AT408446B (de) 1999-02-18 2001-11-26 Altmann Friedrich Dr Fucosyltransferase-gen
EP2275540B1 (en) 1999-04-09 2016-03-23 Kyowa Hakko Kirin Co., Ltd. Method for controlling the activity of immunologically functional molecule
NZ522320A (en) * 2000-05-12 2007-03-30 Neose Technologies Inc In vitro modification of glycosylation patterns of recombinant glycopeptides
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US8008252B2 (en) 2001-10-10 2011-08-30 Novo Nordisk A/S Factor VII: remodeling and glycoconjugation of Factor VII
US7214660B2 (en) * 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7157277B2 (en) 2001-11-28 2007-01-02 Neose Technologies, Inc. Factor VIII remodeling and glycoconjugation of Factor VIII
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
DE60336555D1 (de) 2002-06-21 2011-05-12 Novo Nordisk Healthcare Ag Pegylierte glykoformen von faktor vii
WO2004058960A1 (ja) 2002-12-26 2004-07-15 Kyowa Hakko Kogyo Co., Ltd. ジペプチドの製造法
AU2004221824B2 (en) 2003-03-14 2009-08-27 Ratiopharm Gmbh Branched water-soluble polymers and their conjugates
CA2522345A1 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
US8791070B2 (en) 2003-04-09 2014-07-29 Novo Nordisk A/S Glycopegylated factor IX
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
US8633157B2 (en) 2003-11-24 2014-01-21 Novo Nordisk A/S Glycopegylated erythropoietin
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
US20060040856A1 (en) 2003-12-03 2006-02-23 Neose Technologies, Inc. Glycopegylated factor IX
NZ548123A (en) 2004-01-08 2010-05-28 Novo Nordisk As O-linked glycosylation of peptides
EP1616963B1 (en) 2004-06-25 2009-11-18 Kyowa Hakko Bio Co., Ltd. Process for producing dipeptides or dipeptide derivatives
WO2006010143A2 (en) 2004-07-13 2006-01-26 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1]
WO2006031811A2 (en) 2004-09-10 2006-03-23 Neose Technologies, Inc. Glycopegylated interferon alpha
EP1814573B1 (en) 2004-10-29 2016-03-09 ratiopharm GmbH Remodeling and glycopegylation of fibroblast growth factor (fgf)
CA2593682C (en) 2005-01-10 2016-03-22 Neose Technologies, Inc. Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20080255026A1 (en) 2005-05-25 2008-10-16 Glycopegylated Factor 1X Glycopegylated Factor Ix
FI20055398A0 (fi) 2005-07-08 2005-07-08 Suomen Punainen Risti Veripalv Menetelmä solupopulaatioiden evaluoimiseksi
US20070105755A1 (en) * 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
WO2007066698A1 (ja) 2005-12-06 2007-06-14 Kyowa Hakko Kogyo Co., Ltd. 抗ｐｅｒｐ遺伝子組換え抗体
ES2382207T3 (es) 2005-12-27 2012-06-06 Kyowa Hakko Bio Co., Ltd. Procedimiento para la producción de L-glutamina
KR20090029227A (ko) 2006-06-06 2009-03-20 교와 핫꼬 기린 가부시키가이샤 헤파린 결합 상피세포 증식 인자 유사 증식 인자에 결합하는 모노클로날 항체
CN101516388B (zh) 2006-07-21 2012-10-31 诺和诺德公司 通过o-联糖基化序列的肽的糖基化
WO2008038613A1 (fr) 2006-09-25 2008-04-03 Kyowa Hakko Bio Co., Ltd. Procédé de production de dipeptide
US8969532B2 (en) 2006-10-03 2015-03-03 Novo Nordisk A/S Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography
EP2107115A1 (en) 2007-01-24 2009-10-07 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
CA2676529C (en) 2007-01-24 2014-03-25 Kyowa Kirin Co., Ltd. Genetically recombinant antibody composition having enhanced effector activity
US20100075343A1 (en) 2007-01-25 2010-03-25 Motoo Yamasaki Novel peptides
KR20090130029A (ko) * 2007-03-07 2009-12-17 글리코파이, 인크. 푸코실화가 변형된 당단백질의 제조
WO2008114733A1 (ja) 2007-03-16 2008-09-25 Kyowa Hakko Kirin Co., Ltd. 抗Claudin-4抗体
EP2144923B1 (en) 2007-04-03 2013-02-13 BioGeneriX AG Methods of treatment using glycopegylated g-csf
WO2008154639A2 (en) 2007-06-12 2008-12-18 Neose Technologies, Inc. Improved process for the production of nucleotide sugars
US8207112B2 (en) 2007-08-29 2012-06-26 Biogenerix Ag Liquid formulation of G-CSF conjugate
CA2707689A1 (en) 2007-12-05 2009-06-11 Kyowa Hakko Kirin Co., Ltd. Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
US20130189239A1 (en) 2008-02-27 2013-07-25 Novo Nordisk A/S Conjugated Factor VIII Molecules
CA2729567C (en) 2008-06-30 2018-04-24 Kyowa Hakko Kirin Co., Ltd. Anti-cd27 antibody
EP2166085A1 (en) 2008-07-16 2010-03-24 Suomen Punainen Risti Veripalvelu Divalent modified cells
US8268592B2 (en) 2008-07-17 2012-09-18 Kyowa Hakko Kirin Co., Ltd Anti-system ASC amino acid transporter 2 (ASCT2) antibody
CA2739881A1 (en) 2008-10-09 2010-04-15 Kyowa Medex Co., Ltd. Novel fructosyl peptide oxidase
ES2602459T3 (es) 2008-12-26 2017-02-21 Kyowa Hakko Kirin Co., Ltd. Anticuerpo anti-CD4
JP5694921B2 (ja) 2009-04-20 2015-04-01 協和発酵キリン株式会社 アミノ酸変異が導入されたＩｇＧ２を有する抗体
CA2791652C (en) 2010-03-02 2018-06-12 Kyowa Kirin Co., Ltd. Modified antibody composition
CN103079644B (zh) 2010-06-11 2017-02-15 协和发酵麒麟株式会社 抗tim‑3抗体
WO2012017925A1 (ja) 2010-08-02 2012-02-09 協和発酵キリン株式会社 物質の製造方法
US9611458B2 (en) 2010-12-27 2017-04-04 Kyowa Hakko Kirin Co., Ltd Method for preparing aqueous solution containing culture medium and chelating agent
WO2012176779A1 (ja) 2011-06-20 2012-12-27 協和発酵キリン株式会社 抗ｅｒｂＢ３抗体
DK2852610T3 (en) 2012-05-23 2018-09-03 Glykos Finland Oy PRODUCTION OF FUCOSYLED GLYCOPROTEIN
CA2874117C (en) 2012-07-02 2021-10-12 Kyowa Hakko Kirin Co., Ltd. Pharmaceutical agent comprising anti-bmp9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia
CN104884617B (zh) 2012-12-07 2019-02-19 协和发酵麒麟株式会社 抗folr1抗体
CN105431533B (zh) 2013-07-09 2019-06-28 协和梅迪克斯株式会社 糖化六肽氧化酶及其用途
AU2015293949B2 (en) 2014-07-21 2019-07-25 Teknologian Tutkimuskeskus Vtt Oy Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
US11453900B2 (en) * 2014-09-09 2022-09-27 Glycosyn LLC Alpha (1,3) fucosyltransferases for use in the production of fucosylated oligosaccharides
US11912775B2 (en) 2017-07-18 2024-02-27 Kyowa Kirin Co., Ltd. Anti-human CCR1 monoclonal antibody
CA3071073A1 (en) 2017-07-26 2019-01-31 Spiber Inc. Modified fibroin
AU2018363922B2 (en) 2017-11-08 2025-06-12 Kyowa Kirin Co., Ltd. Bispecific antibody which binds to CD40 and EpCAM
WO2019117208A1 (ja) 2017-12-12 2019-06-20 協和発酵キリン株式会社 抗ｂｍｐ１０抗体及び該抗体を有効成分とする、高血圧および高血圧性疾患に対する治療剤
CA3104997A1 (en) 2018-06-26 2020-01-02 Kyowa Kirin Co., Ltd. Antibody binding to chondroitin sulfate proteoglycan 5
CN112424358B (zh) 2018-06-26 2025-07-01 协和麒麟株式会社 与细胞粘附分子3结合的抗体
EP3875595A4 (en) 2018-11-02 2022-07-13 Kyowa Kirin Co., Ltd. Liquid medium preparation method
KR102991359B1 (ko) 2018-12-28 2026-07-16 쿄와 기린 가부시키가이샤 TfR에 결합하는 이중 특이적 항체
CN113260745A (zh) 2019-01-09 2021-08-13 丝芭博株式会社 改造丝心蛋白
CA3140385A1 (en) 2019-05-15 2020-11-19 Kyowa Kirin Co., Ltd. Bispecific antibody binding to cd40 and fap
WO2020230901A1 (ja) 2019-05-15 2020-11-19 協和キリン株式会社 Ｃｄ４０とｇｐｃ３に結合するバイスペシフィック抗体
TWI888487B (zh) 2020-02-14 2025-07-01 日商協和麒麟股份有限公司 與ｃｄ３結合之雙特異性抗體
US20230128695A1 (en) 2020-03-16 2023-04-27 Spiber Inc. Synthetic Polymer and Method for Producing Same, Molding Material, and Molded Body
CN112795583A (zh) * 2020-11-16 2021-05-14 上海大学 重组唾液酸外切酶的制备方法、表达基因、重组表达载体及构建方法
TW202317637A (zh) 2021-08-26 2023-05-01 日商協和麒麟股份有限公司 與cd116及cd131結合之雙特異性抗體
JPWO2023090372A1 (pt) 2021-11-16 2023-05-25
CA3252263A1 (en) 2022-02-09 2025-07-07 National Institutes Of Biomedical Innovation, Health And Nutrition ANTIBODY OR FRAGMENT OF IT BINDING TO FCRL1
CN119677855A (zh) 2022-08-10 2025-03-21 协和麒麟株式会社 抗fgf23抗体或该抗体片段
CN120283054A (zh) 2022-12-09 2025-07-08 麒麟控股株式会社 具有聚对苯二甲酸乙二醇酯分解活性的蛋白质和分解聚对苯二甲酸乙二醇酯的方法
CN120641468A (zh) 2023-02-03 2025-09-12 丝芭博株式会社 高分子化合物的制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991012340A1 (en) 1990-02-14 1991-08-22 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules
US5324663A (en) * 1990-02-14 1994-06-28 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US5595900A (en) 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1994023021A1 (fr) 1993-03-29 1994-10-13 Kyowa Hakko Kogyo Co., Ltd. α-1,3-FUCOSYLTRANSFERASE

Also Published As

Publication number Publication date
US7094530B1 (en) 2006-08-22
HK1012028A1 (en) 1999-07-23
EP0643132A1 (en) 1995-03-15
EP0643132A4 (en) 1999-01-13
EP0643132B1 (en) 2006-05-31
SG49117A1 (en) 1998-05-18
US20060246468A1 (en) 2006-11-02
US7709234B2 (en) 2010-05-04
JP3756946B2 (ja) 2006-03-22
DE69434749T2 (de) 2007-04-26
DE69434749D1 (de) 2006-07-06
WO1994023021A1 (fr) 1994-10-13

Similar Documents

Publication Publication Date Title
BR9713294A (pt) "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"
BR9508053A (pt) Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga
BR9400656A (pt) Conjunto de controle para controlar um sistema, terminal de saída de imagem, e, processo para controlar um sistema
BR9205834A (pt) Sistema de radiotelefonia, e processo de verificação de um canal-alvo.
BR9810654B1 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
FI20050243L (fi) Stabiilia bakterisidista/läpäisevyyttä parantavaa proteiinifragmenttia koodittava DNA, vektori, isäntäsolu ja menetelmä näiden proteiinipigmenttien valmistamiseksi
EP0660234A3 (en) Remote code execution method and system.
EP0632286A3 (en) Self-adjusting method and device for determining direction based on self-structure.
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
NO910982L (no) Uratoksydase-aktivt protein, rekombinant gen som koder for det, ekspresjonsvektor, mikroorganismer og transformerteceller.
DE69819789D1 (de) Mit einem neuen plasmid transformierter e.coli stamm jm83/pkp2 und damit hergestellte phytase
BR9302511A (pt) Derivados de 4-benzoilisoxazol,processo para suas preparacoes,composicao herbicida e metodo de controle herbicida
BRPI9600729B8 (pt) vetor de expressão, microorganismo transgênico, processo de clonagem de um ácido nucléico e processo para preparação de uma proteína e cepa de levedura transformada
BR9202785A (pt) Processo de montagem de conjunto de valvula para compressor de pistao em movimento alternado,e o respectivo compressor
BR9503132A (pt) Sistema de controle para queimador de combustivel gasoso método para controlar a operação de um queimador de gás combustivel,sistema de controle para controlar a operação de um queimador de combustivel gasoso,metodo para controlar a operação de quimador de combustivel gasoso método para controlar a operação de queimador de combustivel gasoso e método para controlar um queimador de combustivel gasoso
AU676277B2 (en) DNA fragment, vector containing the DNA fragment, transformant transformed with the vector and process for producing protein using the vector
DK509985D0 (da) Antibiotisk polypeptid, fremgangsmaade til dets fremstilling samt dets anvendelse
DE69300904D1 (de) Steuerventil mit gekerbten Steuerflächen für eine Lenkung.
BR9306150A (pt) Endo--1,4-glucanase sequéncia de dna recombinante vetor hospedeiro transformado contendo o vetor processo para a produç o de endo- -1,4-glucanase preparaç o de enzima e uso de endo- -1,4-glucanase
NO995959L (no) DNA-sekvens, vektor, transformerte eukaryote eller prokaryote vertsceller, fremgangsmater for fremstilling av et protein, polypeptid, antistoff, fremgangsmate for isolering og identifisering, farmasoytisk sammensetning og fremgangsmate for screening.
ITGE930084A0 (it) Sicura,in particolare per fucili subaquei o simili.
AU4090393A (en) Fowl mycoplasma antigen, gene thereof, recombinant vector containing said gene, and vaccine prepared by utilizing the same
ITGE930005A0 (it) Forno a longheroni per il riscaldo accelerato di billette, o simili.
EP1251176A3 (en) Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide
DK312787D0 (da) Polypeptider, fremgangsmaade til deres fremstilling, dna som koder for polypeptiderne, vektorer indeholdende saadanne gensekvenser og laegemidler indeholdende polypeptiderne